Finally, to investigate the clinical significance of PLK1 expression in breast cancer, we grouped tumors into those with low PLK1 expression (bottom quartile PLK1 expression) and those with higher PLK1 expression (remaining quartiles). The gene discussed is PLK1; the disease is breast cancer.